08/02/2024

EuropaBio welcomes and warns on New Genomic Techniques European Parliament vote

The New Genomic Techniques (NGTs) legislation vote in the European Parliament is a welcome modernisation of Europe’s biotechnology innovation, food security and climate change response. However, EuropaBio red flags the dangerous fragmentation and weakening of industrial policy with the ban on patenting of NGT plants.
07/02/2024

EuropaBio joins the PRIMED PROJECT CONSORTIUM

EuropaBio, the leading voice for the biotechnology industry in Europe, has joined the PRIMED (Redesigning the Primary Sector for Maximizing Bioeconomy Development) PROJECT CONSURTIUM, launched on January 12th, 2024, and supported by the European Union’s Horizon Europe Program.
23/05/2023

EuropaBio: Biomanufacturing and pharma legislation in the spotlight at the BIO International Convention 2023

Brussels, May 2023 – EuropaBio flies the flag for European biotechnology at the highly anticipated BIO International Convention 2023, scheduled to take place in Boston, MA on 5-8 June and one of the largest biotech industry events worldwide with 100+ interactive sessions across 4 days covering all aspects of business, policy, trade and science.
04/05/2023

What do EuropaBio Members recommend for successful biomanufacturing in Europe?

On 27th April, EuropaBio organised a webinar to follow-up on the Biomanufacturing Policy Summit and officially release the policy recommendations resulting from the summit discussions and post-analysis. The outcome was a set of 10 policy recommendations that will be further developed by EuropaBio and shared in due course with policymakers and wider audience.